Trial intelligence / Profile preview

Pilot Study of Intrinsa Testosterone Patch Added to Hormone Replacement Therapy in Postmenopausal Women

2009-013275-21Phase 4Completed

Sponsor
Imperial College Healthcare NHS Trust
Start
Sep 2009
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, single-arm trial of testosterone in arteriosclerosis, insulin resistance (IR), hypoactive sexual desire disorder (HSDD) and 1 more, sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Arterial compliance and Insulin resistance. Started Sep 2009; status: completed.

02

Drugs

testosterone
03

Conditions

arteriosclerosisinsulin resistance (IR)hypoactive sexual desire disorder (HSDD)hirsutism

Beyond the preview

Go deeper on 2009-013275-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013275-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call